SEDASTART 1 MG/ML SOLUTION FOR INJECTION FOR CATS AND DOGS
Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Vara einkenni
(SPC)
31-05-2016
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
MEDETOMIDINE HYDROCHLORIDE
Fáanlegur frá:
Le Vet BV
ATC númer:
QN05CM91
INN (Alþjóðlegt nafn):
MEDETOMIDINE HYDROCHLORIDE
Skammtar:
1 Mg/Ml
Lyfjaform:
Solution for Injection
Gerð lyfseðils:
VPO-Vet.Practitioner Only
Meðferðarhópur:
Canine, Feline
Lækningarsvæði:
Medetomidine
Ábendingar:
Neurological Preparations
Leyfisstaða:
Authorised
Leyfisdagur:
2010-04-23
Vara einkenni
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Sedastart 1 mg/ml solution for injection for cats and dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml solution for injection contains:
_Active substance:_
Medetomidine hydrochloride
1.0 mg
(equivalent to 0.85 mg medetomidine)
_Excipients:_
Methyl parahydroxybenzoate (E 218)
1.0 mg
Propyl parahydroxybenzoate
0.2 mg
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for injection.
A clear colourless, sterile aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dog and Cat
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_In dogs and cats:_
Sedation to facilitate handling. Premedication prior to general anaesthesia.
_In cats:_
In combination with ketamine for general anaesthesia for minor surgical procedures of short duration.
4.3 CONTRAINDICATIONS
Do not use in animals with:
-
severe cardiovascular disease or respiratory diseases or impaired liver or kidney function.
-
mechanical disturbances of the gastrointestinal tract (torsio ventriculi, incarcerations, oesophagal
obstructions).
-
pregnancy.
-
diabetes mellitus.
-
state of shock, emaciation or serious debilitation.
Do not use concomitantly with sympathomimetic amines.
Do not use in cases of known hypersensitivity to the active substance or to any other excipients.
Do not use in animals with ocular problems where an increase in intraocular pressure would be detrimental.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 16/05/2016_
_CRN 7022211_
_page number: 1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Medetomidine may not provide analgesia throughout the entire period of sedation, therefore consideration should be
given to providi
Lestu allt skjalið
